source
- Galderma receives FDA complete response letter for anti-wrinkle neuromodulatorGalderma has been issued a complete response letter by the U.S. Food and Drug Administration for its experimental anti-wrinkle product relabotulinumtoxinA, which was under review as a neuromodulato…
- Sandoz launches direct-to-consumer platform with growth-hormone biosimilar OmnitropeSandoz announced a direct-to-consumer platform, initially offering Omnitrope, a biosimilar growth hormone for growth disorders. The approach follows a trend among brand-name manufacturers to lower…